Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Rang în acțiuni
#3625
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Preț acțiune
$3.71
Capitalizare de piață
$4.69B
Schimbare (1 zi)
2.44%
Schimbare (1 an)
-51.92%
Țară
CN
Tranzacționează Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Categorie
Healthcare
Raport P/S pentru Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Raport P/S la data de October 2026 TTM: 15.67
Conform celor mai recente rapoarte financiare și prețului acțiunilor Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., raportul P/S actual (TTM) este 15.67. La sfârșitul anului 2023, compania avea un P/S de 17.18.
Istoricul raportului P/S pentru Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. din 2013 până în 2026
Raport P/S la sfârșitul fiecărui an
| An | Raport P/S | Schimbă |
|---|---|---|
| 2026 (TTM) | 15.67 | -62.38% |
| 2024 | 41.67 | 142.53% |
| 2023 | 17.18 | 69.95% |
| 2022 | 10.11 | -48.04% |
| 2021 | 19.46 | -35.13% |
| 2020 | 29.99 | 775.33% |
| 2019 | 3.43 | -14.52% |
| 2018 | 4.01 | 1.37% |
| 2017 | 3.95 | -11.91% |
| 2016 | 4.49 | -19.44% |
| 2015 | 5.57 | -11.75% |
| 2014 | 6.31 | -13.45% |
| 2013 | 7.30 | 0.00% |
Raport P/S pentru companii similare sau competitoare
| Companie | Raport P/S | Diferență raport P/S | Țara |
|---|---|---|---|
| 10.02 | -36.06% |
US
|
|
| 40.55 | 158.70% |
US
|
|
| 3.96 | -74.73% |
AU
|
|
| - | - |
CH
|
|
| 10.15 | -35.27% |
NL
|
